Gem Pharmaceuticals
About:
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically
Website: http://gempharmaceuticals.com
Top Investors: Diane Hendricks, Karl Leo
Description:
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.
Total Funding Amount:
$4.5M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Birmingham, Alabama, United States
Founded Date:
2003-01-01
Founders:
Richard Olson
Number of Employees:
1-10
Last Funding Date:
2014-03-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai